`
Home
About Us
Structure
Current Events
Past Events
Policy & Reports
Awards
Membership
Media Coverage
Internship/Volunteers
Legal
Contact Us
 
 

USA India Chamber of Commerce has created an exclusive BioPharma innovation ecosystem for senior industry executives, academicians, investors and policy makers to Learn, Share, Deliberate and Network. This unique platform creates mutually beneficial opportunities and relationships for the global Healthcare & Life Sciences industry.

   
11th US-India BioPharma & Healthcare Summit, Thursday, May 18, 2017

BioPharma & Healthcare Summit 2017

Emcee - Dr. Andrew Plump, Chief Medical & Scientific Officer, Takeda


* Speakers and Timings subject to change

Time Topic
8-45 AM - 9-15 AM Registration and Networking
9-15 AM - 9-30 AM Welcome address by Karun Rishi, President, USA-India Chamber of Commerce

Opening comments by - Dr Andrew Plump, Chief Medical & Scientific Officer, Member of the Board of Directors, Takeda Pharmaceuticals
9-30 AM - 9-55 AM India Regulatory and Clinical Research Update
Dr. R.K. Vats , IAS, Additional Secretary, Ministry of Health and Family Welfare, Government of India
9-55 AM - 10-45 AM Panel Discussion: Oncology

Panelists:
  • Dr. Edward Benz, President & CEO Emeritus, Dana Farber Cancer Institute
  • Dr. Vijay Chandru, Chairman, Strand Life Sciences
  • Dr. Timothy Clackson, President R&D and CSO, Ariad Pharmaceuticals
  • Dr. Jeffrey Engelman, Global Head of Oncology Research, Novartis Institutes for BioMedical Research
  • Dr. Rakesh Jain, E.L. Steele Laboratory of Tumor Biology,  MGH Cancer Center/ Harvard Medical School
Moderator:
Dr. Vijay Kuchroo, Director- Evergrande Center for Immunologic Diseases, Brigham & Women's Hospital/ Harvard Medical School
10-45 AM - 11-15 AM Fireside Chat with Dr. Richard Moscicki, Deputy Director (Science Operations), Center for Drug Evaluation and Research, USFDA and Dr. Chris Austin, Director, National Center for Advancing Translational Sciences, National Institutes of Health
Moderator:
Dr. William Chin, Executive Vice President and Chief Medical Officer, PhRMA
11-15 AM -11-45 AM Networking & Tea Break
11-45 AM - 12-35 PM Panel Discussion: Vaccines

Panelists:
  • Dr. Stephen Caddick, Director of Innovation, Wellcome Trust
  • Dr. Johan Van Hoof, Global Therapeutic Head- Infectious Diseases & Vaccines, Janssen Pharmaceutical Companies of Johnson & Johnson
  • Dr. Gagandeep Kang, Executive Director, Translational Health Science & Technology Institute (THISTI)
  • Michael Nally, President, Merck Vaccines, Merck & Co.
  • Dr. Niranjan Sardesai, Chief Operating Officer, Inovio Pharmaceuticals
Moderator:
Dr. William Chin, Executive Vice President and Chief Medical Officer, PhRMA
12-35 PM - 1-05 PM

Fireside Chat with Sanat Chattopadhyay, President, Merck Manufacturing Division, Merck & Co.and Dr. R. K. Vats, IAS, Additional Secretary, Ministry of Health and Family Welfare, Government of India

Moderator:
Dr. Amrit Ray, Chief Medical Officer, Janssen Pharmaceutical Companies of Johnson & Johnson

1-05 PM - 2-40 PM Luncheon Panel Discussion: Clinical Trials & Regulatory

Panelists:
  • Dr. Richard Moscicki, Deputy Director (Science Operations), CDER, USFDA
  • Dr. Petra Kaufmann, Director, Office of Rare Diseases Research & Director, Division of Clinical Innovation- NCATS, National Institutes of Health
  • Dr. G.N. Singh, Drug Controller General of India, Central Drugs Standard Control Organization, Ministry of Health
  • K.V. Subramaniam, President, Reliance Life Sciences
  • Dr. Tsutomu Une, Senior Corporate Advisor, GCA Corporation
Moderator:
Dr. Michael Rosenblatt, Chief Medical Officer, Flagship Pioneering
2-40 PM - 3-15 PM Networking & Tea Break
3-15 PM - 4-05 PM Panel Discussion: Rare & Neglected Diseases

Panelists:
  • Dr. Chris Austin, Director, National Center for Advancing Translational Sciences, National Institutes of Health
  • Dr. Jim Burns, President and CEO, Casebia Therapeutics
  • Dr David Meeker, Executive Vice President & Head, Sanofi Genzyme
  • Dr. Wim Parys, Head of R&D- Global Public Health, Janssen Pharmaceutical companies of Johnson & Johnson
  • Dr. Alfred Sandrock, Executive Vice President & Chief Medical Officer, Biogen
Moderator:
Dr. Steve Uden, Head of Research, Alexion Pharmaceuticals
4-05 PM - 4-55 PM Panel Discussion: Drug Discovery and Development

Panelists:
  • Dr. James Bradner, President, Novartis Institutes for BioMedical Research
  • Dr. William Hait, Global Head- Research & Development, Janssen Pharmaceutical Companies of Johnson & Johnson
  • Dr. David Nicholson, Chief R&D Officer, Allergan
  • Dr Andrew Plump, Chief Medical & Scientific Officer and Director, Takeda Pharmaceuticals
Moderator:
Dr. Martin Mackay, Executive Vice President and Global Head of R&D, Alexion Pharmaceuticals
4-55 PM - 5-00 PM Closing Remarks
5-00 PM - 6-15 PM Cocktails & Networking Reception

 

* Speaker and Timings subject to change

Pharmasia News   Biospectrum India Online
© 2007 - USA India Chamber of Commerce Home | About us | Agenda | Council | Policy | Events | Photo Gallery | Awards | Membership | Membership Form | Internship/Volunteers | Legal | Contact us